AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Kazia Therapeutics Soars 11.45% on Reverse Split
Generated by AI AgentAinvest Pre-Market Radar
Tuesday, Jul 8, 2025 7:17 am ET1min read
On July 8, 2025, Kazia Therapeutics' stock surged by 11.45% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.
Kazia Therapeutics has been the subject of various forecasts and price targets. Analysts have predicted that the stock could rise by 80.57% over the next three months, with a 90% probability of holding a price between $9.99 and higher. Additionally, the average twelve-month price target for the stock is $57.50, with some analysts setting a high target of $100.00.
Recent corporate actions have also impacted the stock.
recently performed a 1 for 5 reverse split, which means shareholders now hold 1 share for every 5 they previously owned. This action is often taken to increase the stock price and attract more investors.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Serve Robotics Surges 5.16% as Trump Admin Boosts Robotics Push, Eyes 10X Revenue by 2026
Dec.12 2025
New Pacific Metals (NPM) Soars 7.98% as Base Metals Market Anticipates Supply/Demand Shifts
Dec.12 2025
Gevo Inc. (GEVO) Surges 6.22% on $26M BioRecro Partnership to Expand Carbon Management Capabilities
Dec.12 2025
Sable Offshore Soars 5.82% as Private Placement and Policy Tailwinds Drive Pre-Market Rally
Dec.12 2025
Mastercard Inc. Surges 4.55% as Fintech Optimism and AI Expansion Drive Pre-Market Rally
Dec.12 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet